mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |